|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,186,888 |
|
|
Indirect Value
|
$499,113,789 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$500,300,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
10.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 25
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2014-02-25 |
4 |
AS |
$80.08 |
$1,008,946 |
D/D |
(12,600) |
2,251,660 |
0 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-11-10 |
4 |
B |
$32.73 |
$1,123,383 |
D/D |
34,320 |
10,102,337 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2014-11-03 |
4 |
B |
$9.23 |
$1,134,318 |
D/D |
122,900 |
7,093,436 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-02-03 |
4 |
S |
$110.44 |
$1,169,007 |
D/D |
(10,585) |
9,887,848 |
0 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-10-04 |
4 |
B |
$37.93 |
$1,233,649 |
D/D |
32,523 |
9,296,950 |
2.45 |
% |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2014-01-23 |
4 |
AS |
$65.00 |
$1,300,000 |
D/D |
(20,000) |
2,776,660 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2017-02-17 |
4 |
OE |
$3.25 |
$1,381,250 |
D/D |
425,000 |
3,056,680 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
10% Owner |
|
2014-01-29 |
4 |
AS |
$66.10 |
$1,652,375 |
D/D |
(25,000) |
2,751,660 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
10% Owner |
|
2014-01-30 |
4 |
AS |
$67.01 |
$1,675,350 |
D/D |
(25,000) |
2,726,660 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2017-07-21 |
4 |
OE |
$3.25 |
$1,755,000 |
D/D |
540,000 |
3,596,680 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-09-23 |
4 |
OE |
$3.15 |
$1,807,836 |
D/D |
573,461 |
17,349,945 |
0 |
- |
|
PMTI |
Palomar Medical Technolog... |
10% Owner |
|
2012-05-30 |
4 |
B |
$8.15 |
$1,808,158 |
D/D |
221,800 |
2,755,023 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2024-01-04 |
4 |
B |
$28.91 |
$1,828,183 |
D/D |
63,246 |
10,607,654 |
2.45 |
% |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-02-25 |
4 |
B |
$3.74 |
$1,870,000 |
D/D |
500,000 |
9,822,262 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2022-12-29 |
4 |
B |
$47.93 |
$1,873,431 |
D/D |
39,090 |
8,783,082 |
2.45 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-02-08 |
4 |
B |
$3.75 |
$1,999,999 |
D/D |
533,333 |
8,098,267 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-07-02 |
4 |
B |
$2.00 |
$2,000,000 |
D/D |
1,000,000 |
9,098,267 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-06-18 |
4 |
S |
$152.59 |
$2,019,681 |
D/D |
(13,236) |
8,892,682 |
0 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2009-06-16 |
4 |
B |
$1.88 |
$2,179,601 |
D/D |
1,159,362 |
6,028,638 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2019-05-03 |
4 |
B |
$22.23 |
$2,223,000 |
D/D |
100,000 |
10,840,630 |
2.45 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-05-21 |
4 |
OE |
$2.34 |
$2,340,000 |
D/D |
1,000,000 |
1,641,025 |
0 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-04-24 |
4 |
B |
$2.27 |
$2,383,500 |
D/D |
1,050,000 |
14,716,204 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2022-12-27 |
4 |
B |
$47.91 |
$2,490,534 |
D/D |
51,985 |
8,643,992 |
2.45 |
% |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-11-14 |
4 |
S |
$62.31 |
$2,496,237 |
D/D |
(40,000) |
4,183 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-02-10 |
4 |
A |
$3.90 |
$2,499,998 |
D/D |
641,025 |
641,025 |
0 |
- |
|
612 Records found
|
|
Page 22 of 25 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|